Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gender-specific Role of the beta2-adrenergic Stimulation With Short- or Long-acting Selective Agonist in Relation to Muscle Remodelling, Function, Performance, and Anti-doping

NCT03565302 is registered in ClinicalTrials.gov with Morten Hostrup, PhD as lead sponsor.

NCT NCT03565302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03565302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gender-specific Role of the beta2-adrenergic Stimulation With Short- or Long-acting Selective Agonist in Relation to Muscle Remodelling, Function, Performance, and Anti-doping
Lead sponsor
Morten Hostrup, PhD
Phase
Not applicable
Overall status
Unknown status
Start date
June 25, 2018
Completion date
May 30, 2021
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophy, physical activity, physiologic hypertrophy